170 related articles for article (PubMed ID: 35143585)
1. The association between migraine and breast cancer risk: A systematic review and meta-analysis.
Hesari E; Ahmadinezhad M; Arshadi M; Azizi H; Khodamoradi F
PLoS One; 2022; 17(2):e0263628. PubMed ID: 35143585
[TBL] [Abstract][Full Text] [Related]
2. Migraine and breast cancer risk: a meta-analysis of observational studies based on MOOSE compliant.
Wu X; Wang M; Li S; Zhang Y
Medicine (Baltimore); 2016 Jul; 95(30):e4031. PubMed ID: 27472675
[TBL] [Abstract][Full Text] [Related]
3. Migraine in postmenopausal women and the risk of invasive breast cancer.
Mathes RW; Malone KE; Daling JR; Davis S; Lucas SM; Porter PL; Li CI
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3116-22. PubMed ID: 18990752
[TBL] [Abstract][Full Text] [Related]
4. The risk of breast cancer associated with specific patterns of migraine history.
Lowry SJ; Malone KE; Cushing-Haugen KL; Li CI
Cancer Causes Control; 2014 Dec; 25(12):1707-15. PubMed ID: 25359301
[TBL] [Abstract][Full Text] [Related]
5. Dietary Patterns and Risk of Invasive Ductal and Lobular Breast Carcinomas: A Systematic Review and Meta-analysis.
Dianatinasab M; Rezaian M; HaghighatNezad E; Bagheri-Hosseinabadi Z; Amanat S; Rezaeian S; Masoudi A; Ghiasvand R
Clin Breast Cancer; 2020 Aug; 20(4):e516-e528. PubMed ID: 32362500
[TBL] [Abstract][Full Text] [Related]
6. Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women.
Li CI; Mathes RW; Malone KE; Daling JR; Bernstein L; Marchbanks PA; Strom BL; Simon MS; Press MF; Deapen D; Burkman RT; Folger SG; McDonald JA; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2030-4. PubMed ID: 19589913
[TBL] [Abstract][Full Text] [Related]
7. Migraine and breast cancer risk: a prospective cohort study and meta-analysis.
Winter AC; Rice MS; Fortner RT; Eliassen AH; Kurth T; Tamimi RM
J Natl Cancer Inst; 2015 Jan; 107(1):381. PubMed ID: 25505231
[TBL] [Abstract][Full Text] [Related]
8. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
[TBL] [Abstract][Full Text] [Related]
9. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Coates RJ; Marchbanks PA; Norman SA; Weiss LK; Ursin G; Berlin JA; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Wingo PA; Spirtas R
Cancer; 2002 Dec; 95(12):2455-64. PubMed ID: 12467057
[TBL] [Abstract][Full Text] [Related]
10. Migraine and Risk of Breast Cancer: A Systematic Review and Meta-analysis.
Peng C; Wu K; Chen X; Lang H; Li C; He L; Chen N
Clin Breast Cancer; 2023 Apr; 23(3):e122-e130. PubMed ID: 36624014
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
Li CI; Weiss NS; Stanford JL; Daling JR
Cancer; 2000 Jun; 88(11):2570-7. PubMed ID: 10861435
[TBL] [Abstract][Full Text] [Related]
12. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
Li CI; Anderson BO; Daling JR; Moe RE
JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
[TBL] [Abstract][Full Text] [Related]
13. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
15. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW
Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159
[TBL] [Abstract][Full Text] [Related]
16. Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.
Mathes RW; Malone KE; Daling JR; Porter PL; Li CI
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):67-72. PubMed ID: 18199712
[TBL] [Abstract][Full Text] [Related]
17. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years.
Li CI; Daling JR; Tang MT; Haugen KL; Porter PL; Malone KE
JAMA Intern Med; 2013 Sep; 173(17):1629-37. PubMed ID: 23921840
[TBL] [Abstract][Full Text] [Related]
18. The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women.
Katuwal S; Tapanainen JS; Pukkala E; Kauppila A
BMC Cancer; 2019 Mar; 19(1):199. PubMed ID: 30832620
[TBL] [Abstract][Full Text] [Related]
19. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
[TBL] [Abstract][Full Text] [Related]
20. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
